Peter Kraft Selected Research

idarucizumab

1/2020	Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.
1/2017	Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
5/2016	Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Kraft Research Topics

Disease

93	Neoplasms (Cancer) 01/2023 - 03/2004
91	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2006
65	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 11/2005
47	Stroke (Strokes) 04/2024 - 09/2010
36	Ischemic Stroke 04/2024 - 02/2010
30	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 03/2009
26	Thrombosis (Thrombus) 01/2023 - 02/2010
21	Inflammation (Inflammations) 01/2023 - 04/2008
14	Genetic Risk Score 02/2023 - 11/2013
14	Carcinogenesis 10/2021 - 11/2005
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2009
11	Obesity 10/2023 - 11/2008
11	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 12/2009
11	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2021 - 04/2011
11	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2006
10	Hemorrhage 04/2024 - 02/2010
10	Infarction (Infarctions) 01/2023 - 12/2010
9	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 04/2005
9	Melanoma (Melanoma, Malignant) 07/2021 - 10/2008
9	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2009
9	Cerebral Hemorrhage 01/2020 - 09/2014
8	Genetic Predisposition to Disease (Genetic Predisposition) 10/2022 - 04/2013
8	Brain Ischemia (Cerebral Ischemia) 09/2021 - 02/2010
7	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 09/2010
7	Reperfusion Injury 09/2021 - 09/2013
7	Insulin Resistance 01/2020 - 05/2010
7	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2019 - 01/2013
6	Adenocarcinoma 10/2021 - 04/2011
5	Neuroinflammatory Diseases 01/2023 - 06/2014
5	Hematoma 01/2020 - 02/2015
5	Myocardial Infarction 10/2018 - 02/2007
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 10/2012
4	Triple Negative Breast Neoplasms 12/2022 - 01/2019
4	Glaucoma 10/2019 - 01/2013
4	Multiple Sclerosis 01/2018 - 07/2010
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 10/2014
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 05/2006
3	Hypertension (High Blood Pressure) 01/2021 - 12/2018
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

40	Estrogen ReceptorsIBA 01/2023 - 02/2006
33	Hormones (Hormone)IBA 11/2022 - 11/2005
29	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2007
27	Genetic Markers (Genetic Marker)IBA 01/2023 - 05/2007
26	Proteins (Proteins, Gene)FDA Link 02/2023 - 03/2004
18	Vitamin D FDA LinkGeneric 01/2020 - 01/2009
14	ORALIT (ORS)IBA 01/2023 - 05/2009
14	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2004
13	LipidsIBA 12/2022 - 12/2007
12	AnticoagulantsIBA 01/2023 - 10/2012
12	hydroxide ionIBA 01/2020 - 07/2010
11	25-hydroxyvitamin DIBA 01/2020 - 01/2012
10	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023 - 10/2009
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 04/2005
9	SteroidsIBA 02/2023 - 11/2005
9	Estrogens (Estrogen)FDA Link 01/2020 - 08/2005
9	Testosterone (Sustanon)FDA Link 12/2018 - 08/2005
8	ABO Blood-Group SystemIBA 01/2023 - 03/2009
8	Insulin-Like PeptidesIBA 01/2018 - 01/2009
8	Insulin-Like Growth Factor I (IGF-1)IBA 10/2016 - 07/2008
7	Vitamin K FDA Link 04/2024 - 07/2014
7	Insulin (Novolin)FDA Link 01/2022 - 01/2009
7	EnzymesIBA 11/2017 - 08/2005
7	Prostate-Specific Antigen (Semenogelase)IBA 03/2012 - 12/2005
6	AntigensIBA 01/2023 - 05/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2005
6	N(4)-oleylcytosine arabinosideIBA 09/2021 - 01/2015
6	CytokinesIBA 01/2017 - 10/2008
6	Estradiol (Delestrogen)FDA LinkGeneric 10/2014 - 08/2005
6	AndrogensIBA 10/2014 - 08/2005
5	Dabigatran FDA Link 04/2024 - 01/2016
5	Blood Group Antigens (Blood Groups)IBA 01/2023 - 03/2009
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2009
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 03/2004
5	CarbonIBA 01/2020 - 12/2006
5	Glycoproteins (Glycoprotein)IBA 04/2019 - 04/2011
5	Insulin-Like Growth Factor Binding Protein 3IBA 07/2013 - 07/2008
4	AdiponectinIBA 10/2023 - 01/2012
4	LeptinIBA 10/2023 - 01/2012
4	mahuang-tangIBA 01/2022 - 04/2013
4	HDL CholesterolIBA 01/2022 - 01/2003
4	Carotenoids (Carotene)IBA 01/2022 - 05/2013
4	LDL CholesterolIBA 01/2022 - 01/2017
4	Progesterone FDA LinkGeneric 01/2021 - 01/2010
4	C-Reactive ProteinIBA 01/2021 - 06/2009
4	CholesterolIBA 01/2021 - 01/2003
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2003
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2009
4	Androgen Receptors (Androgen Receptor)IBA 10/2014 - 01/2006
4	Insulin-Like Growth Factor Binding ProteinsIBA 05/2012 - 07/2008
3	AdipokinesIBA 10/2023 - 11/2008
3	InflammasomesIBA 01/2023 - 01/2021
3	Phenobarbital (Luminal)FDA Link 12/2022 - 02/2016
3	Vitamin A (Retinol)FDA LinkGeneric 01/2022 - 12/2011
3	human ERBB2 proteinIBA 01/2022 - 02/2016
3	IronIBA 10/2021 - 01/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2018
3	idarucizumabIBA 01/2020 - 05/2016

Therapy/Procedure

19	Therapeutics 10/2022 - 01/2008
6	Thrombectomy 10/2021 - 02/2016
4	Secondary Prevention 01/2020 - 07/2014